Completed for the National Conference of State Legislatures and the Kaiser Commission on Medicaid and the Uninsured, by Health Management Associates. Compiled from Medicaid State Plans and Amendments approved by the Centers for Medicare and Medicaid Services, and from State websites, with verification by State and Territorial Medicaid officials in March 2003.

This document, prepared by Health Policy Alternatives, Inc., provides a detailed side-by-side comparison of the prescription drug provisions of the Conference Agreement (H.R. 1) passed by the House and Senate in November 2003 and the House (H.R. 1) and Senate (S. 1) Medicare proposals passed in June 2003.

Report (.pdf)

Standard Medicare Drug Benefit, 2006

Out-of-pocket drug spending for Medicare beneficiaries under the standard Medicare drug benefit described in the Medicare Modernization Act of 2003.

Chart (.pdf)

A Video

The Kaiser Commission on Medicaid and the Uninsured’s video profiles five families who have children covered by Medicaid. These five families reflect the diversity of those helped by Medicaid — families from all over the country of varying races/ethnicities, ages and sizes. Each family also illustrates a particular health care need and shows how Medicaid assists in obtaining needed health care services.

Also available in Low Speed. (8 min.)

Brochure

To order a free copy of these videos please email kcmu@kff.org or call The Kaiser Commission on Medicaid and the Uninsured at 202.347.5270.

This Briefing Note explores the issues presented for the design and administration of a new Medicare drug benefit by dually eligible nursing facility residents.

Issue Paper (.pdf)

As the U.S. Congress continues to search for an agreement on the form of a Medicare prescription drug benefit, the Commission has two new reports related to the debate. One new publication reports on findings from an October 26 discussion with state Medicaid officials on the implications of a Medicare drug benefit for states and dual eligibles. The other report provides state-level estimates on spending on dual eligibles and illustrates the effects of scenarios where the federal government assumes the cost of prescription drugs, Medicare premiums, acute care, and long-term care for this population. Additionally, a link to a fact sheet on dual eligibles is provided.

Coordinating Medicaid and Medicare Prescription Drug Coverage

Shifting the Cost of Dual Eligibles: Implications for States and the Federal Government

Dual Enrollees: Medicaid’s Role for Low-Income Medicare Beneficiaries

This issue paper provides state-level estimates on spending on dual eligibles and illustrates the fiscal effects of scenarios where the federal government assumes the cost of prescription drugs, Medicare premiums, acute care, and long-term care for this population.

Issue Paper (.pdf)

This publication reports on the findings from an October 26 focus group discussion with state Medicaid officials on the implications of a Medicare drug benefit for states and dual eligibles.

Report (.pdf)

This report analyzes key issues surrounding the implementation of a Medicare-endorsed prescription drug discount card program. Medicare prescription drug discount cards have been proposed as a short-term strategy for lowering prescription drug costs for Medicare beneficiaries.

The report considers the implications for both discount card sponsors and beneficiaries of alternative program designs, including such features as the annual lock-in for consumers, exclusive formularies, providing comparative information to consumers about drug prices and discounts, administration of low-income subsidies, and the short duration of the program.

Report (.pdf)